HPV and molecular mimicry in systemic lupus erythematosus and an impact of compiling B-cell epitopes and MHC-class II binding profiles with in silico evidence.

Autor: Calvin DJD; Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India., Steve RJ; Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India., Kannangai R; Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India., Abraham P; Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India., Udhaya Kumar S; Laboratory of Integrative Genomics, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India., Balasundaram A; Laboratory of Integrative Genomics, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India., George Priya Doss C; Laboratory of Integrative Genomics, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India., Thomas V; Department of Gynecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India., Thomas A; Department of Gynecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India., Danda D; Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, Tamil Nadu, India., Fletcher JG; Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India.
Jazyk: angličtina
Zdroj: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2023; Vol. 41 (21), pp. 12338-12346. Date of Electronic Publication: 2023 Feb 06.
DOI: 10.1080/07391102.2023.2175261
Abstrakt: Epidemiological link between HPV and SLE is evolving. The possibility of HPV infection-induced molecular mimicry and systemic lupus erythematosus (SLE) was elucidated through detailed in silico analyses. Conserved regions in the structural protein sequences of high-risk HPV types were inferred, and sequence homologies between viral and human peptides were identified to delineate proteins implicated in SLE. B-cell epitopes and MHC-class II binding were compiled using Immune Epitope Database and ProPred II analysis tool. Molecular modeling and molecular dynamics/simulation (MDS) were performed using AutoDock Vina and GROMACS, respectively. Sequence alignment revealed 32 conserved regions, and 27/32 viral peptides showed varying similarities to human peptides, rich in B-cell epitopes with superior accessibility, high hydrophilicity, antigenicity and disposition to bind many class-II HLA alleles. Molecular docking of 13 viral peptides homologous (100%) to human peptides implicated in SLE showed that VIR-PEP1 (QLFNKPYWL) and VIR-PEP2 (DTYRFVTS) exhibited higher binding affinities than corresponding human peptides to SLE predisposing HLA-DRB1 allele. MDS of these peptides showed that the viral peptides had superior folding, compactness, and a higher number of hydrogen bonds than human peptides throughout the simulation period. SASA analysis revealed that the VIR-PEP1&2 fluctuated less frequently than corresponding human peptides. MM-PBSA revealed that the VIR-PEP2 complex exhibited higher binding energy than the human peptide complex. This suggests that highly conserved structural peptides of high-risk HPV types homologous to human peptides could compete and bind avidly to the HLA allele associated with SLE and predispose HPV-infected individuals to SLE through molecular mimicry.Communicated by Ramaswamy H. Sarma.
Databáze: MEDLINE